Pee break: spot urine test could end 24-Hour jug hassle for myeloma patients

NCT ID NCT05208086

Ongoing Diagnosis Sponsor: Intergroupe Francophone du Myelome Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a single urine sample (spot urine) can detect myeloma proteins as accurately as the standard 24-hour urine collection. Researchers will compare results from 180 multiple myeloma patients starting a new treatment. If the spot test works well, it could make monitoring much easier for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could replace the inconvenient 24-hour urine collection with a simple spot urine test for monitoring multiple myeloma.
What could go wrong: This is a diagnostic accuracy study, not a treatment trial. The spot test may not be sensitive enough to replace the standard method, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Locations

CH Bretagne Atlantique Vannes et Auray-P.Chubert

Vannes, France
CH de Dunkerque

Dunkirk, France
CH de Lens

Lens, France
CH de Versailles

Versailles, France
CHD Vendée

La Roche-sur-Yon, France
CHRU Bretonneau

Tours, France
CHRU Nantes

Nantes, France
CHU François Mitterand

Dijon, France
CHU Toulouse

Toulouse, France
CHU de Montpellier

Montpellier, France
Centre Hospitalier Lyon sud

Lyon, France
Centre Hospitalier Métropole de Savoie

Chambéry, France
Ch Annecy Genevois

Annecy, France
Ch Le Mans

Le Mans, France
Chu Pontchaillou

Rennes, France
Hopital Bicètre

Le Kremlin Bicètre, France
Hopital Claude Huriez-CHRU LILLE

Lille, France
Hôpital E. MULLER

Mulhouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.